Novel peptide adjuvant for influenza vaccination

Details Novel peptide adjuvant for influenza vaccination Novel peptide adjuvant for influenza vaccination

A - Human Necessities

61

K

A61K 39/39 (2006.01) A61K 39/145 (2006.01) A61P 31/16 (2006.01) A61P 37/04 (2006.01)

Patent

CA 2727866

The present disclosure generally relates to peptides having adjuvant properties, vaccines comprising the adjuvant peptides, and their use in prophylaxis or therapy for influenza. More particularly, the invention relates to adjuvant peptides that induce aggregation of influenza virus. The peptides can be included in influenza vaccines to increase the immune response to the vaccine.

La présente invention concerne d'une manière générale des peptides ayant des propriétés d'adjuvants, des vaccins comprenant les peptides adjuvants, et leur utilisation dans la prophylaxie ou la thérapie pour la grippe. Plus particulièrement, l'invention porte sur des peptides adjuvants qui induisent une agrégation du virus de la grippe. Les peptides peuvent être inclus dans des vaccins contre la grippe pour augmenter la réponse immunitaire au vaccin.

Affiliated with

Also associated with

Rating

Novel peptide adjuvant for influenza vaccination does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel peptide adjuvant for influenza vaccination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel peptide adjuvant for influenza vaccination will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1491507